Xuezhi Hao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center · ORCID：0000-0002-1285-5562

发表论文 193 篇 · 总被引 1696 次 · h-index 24

代表论文

• Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas (2024 · Signal Transduction and Targeted Therapy · 被引 24)
• Influence of PD‐L1 expression on the efficacy of EGFR ‐TKIs in EGFR ‐mutant non‐small cell lung cancer (2023 · Thoracic Cancer · 被引 13)
• Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy (2024 · Lung Cancer · 被引 8)
• Pyrotinib plus antiangiogenic agents for HER2 ‐altered advanced non‐small cell lung cancer: A retrospective real‐world study (2023 · Thoracic Cancer · 被引 8)
• Low TP53 variant allele frequency as a biomarker for anti‐programmed death (ligand) 1 monotherapy in lung adenocarcinoma (2023 · Cancer · 被引 8)
• Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs (2024 · Journal of Translational Medicine · 被引 7)